NK cell Activation

Natural Killer (NK) cell activation is controlled by a dynamic balance between complementary and antagonistic pathways that are initiated upon interaction with potential target cells. Here is the latest research.


July 10, 2020
Review

Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases

European Journal of Clinical Investigation
Elisa GremeseGianfranco Ferraccioli
July 1, 2020

Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity

The Journal of Immunology : Official Journal of the American Association of Immunologists
Abir K PandaEthan M Shevach
June 18, 2020
Review
Open Access

Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance

Cancers
Elaheh Hashemi, Subramaniam Malarkannan
June 20, 2020

Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies

Cancer Immunology, Immunotherapy : CII
Barry D HockMargaret J Currie
July 11, 2020

Structural basis for RIFIN-mediated activation of LILRB1 in malaria

Nature
Thomas E HarrisonMatthew K Higgins
May 5, 2020
Case Report
Open Access

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma

Gastroenterology Research
Sara KwongJinping Lai
May 19, 2020
Review

HLA-DR-expressing NK cells: Effective killers suspected for antigen presentation

Journal of Leukocyte Biology
Sofya A ErokhinaElena I Kovalenko
May 30, 2020

Impact of Human HLA-E and NKG2C Variants and of HCMV Ul40 Genotype Populations on HCMV Replication in Lung Transplant Recipients

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
H VietzenE Puchhammer-Stöckl
May 30, 2020

Dissection of the HCMV-Specific Antibody Responses in Lung-Transplant Recipients

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
H VietzenE Puchhammer-Stöckl
May 27, 2020
Review

An Update on XMEN Disease

Journal of Clinical Immunology
Juan C RavellMichael Lenardo
June 14, 2020

PET imaging of the natural killer cell activation receptor NKp30

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Travis M ShafferSanjiv S Gambhir
June 17, 2020
Review
Open Access

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy

Journal of Immunology Research
Wioletta OlejarzTomasz Lorenc
May 8, 2020

Human Term Pregnancy Decidual NK Cells Generate Distinct Cytotoxic Responses

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ricardo de Mendonça VieiraTamara Tilburgs
May 14, 2020
Open Access

The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma

Cancer Immunology, Immunotherapy : CII
Daniëlle KrijgsmanMarianne Hokland

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved
/feed-previews/nk-cell-activation/4ff23e94-30d6-403a-bb70-6e8233fa6aad